Tumor size, mean (SD), cm |
5.6 (4.4) |
6.2 (4.3) |
P < .001 |
Bilateral, no. (%) |
134 (14.7) |
57 (13.3) |
P = .51 |
Single tumor, no. (%) |
690 (67.2) |
350 (73.8) |
P = .009 |
Met Milan criteria, no. (%) |
462 (43.8) |
178 (37.4) |
P = .02 |
Normal AFP, no. (%) |
414 (39.4) |
212 (45.0) |
P = .04 |
AFP, mean (SD), ng/mL |
11,980 (54576) |
9743 (60365) |
P = .006 |
Cirrhosis, no. (%) |
774 (74.4) |
303 (64.6) |
P < .001 |
Rupture, no. (%) |
40 (3.8) |
18 (3.8) |
P = .99 |
APRI, mean (SD) |
0.79 (0.84) |
0.45 (0.64) |
P < .001 |
MELD, mean (SD) |
10.5 (4.5) |
10.2 (4.09) |
P = .56 |
Childs–Turcotte–Pugh Score, mean (SD) |
6.5 (2.0) |
5.9 (1.4) |
P < .001 |
Bilirubin, mean (SD), mg/dL |
1.7 (2.7) |
1.2 (1.7) |
P < .001 |
Albumin, mean (SD), g/dL |
3.52 (0.74) |
3.71 (0.63) |
P < .001 |
Prothrombin time, mean (SD), s |
14.6 (2.4) |
14.1 (2.0) |
P < .001 |
INR, mean (SD) |
1.18 (0.27) |
1.13 (0.23) |
P < .001 |
Platelets, mean (SD), 103/μL |
161.3 (95.8) |
183.0 (92.5) |
P < .001 |
Creatinine, mean (SD), mg/dL |
0.98 (0.71) |
1.18 (0.93) |
P < .001 |
AST, mean (SD), IU/L |
91.5 (84.8) |
61.8 (54.2) |
P < .001 |
ALT, mean (SD), IU/L |
67.0 (60.5) |
50.6 (45.2) |
P < .001 |